These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


839 related items for PubMed ID: 5785756

  • 1. [Principles of the treatment of hypercoagulabilities with a rational anticoagulant therapy].
    Raby C.
    Presse Med (1893); 1969 Jan 04; 77(1):17-9. PubMed ID: 5785756
    [No Abstract] [Full Text] [Related]

  • 2. [Biological study of a new antivitamin K anticoagulant 3-(alpha-acetonylbenzyl) 4-hydroxycoumarin dimethylaminoethanol. (100 cases)].
    Migne J, Monteil R, Pessereau G, Pernod J, Siau J.
    Therapie; 1968 Jan 04; 23(3):553-66. PubMed ID: 5740621
    [No Abstract] [Full Text] [Related]

  • 3. [Effect of various laboratory tests in the control of anticoagulant therapy].
    Molinas FC, Sanchez Avalos JC.
    Medicina (B Aires); 1967 Jan 04; 27(2):107-15. PubMed ID: 5600645
    [No Abstract] [Full Text] [Related]

  • 4. [Role of liver maintenance of normal hemostasis].
    Rosiek B.
    Pol Tyg Lek; 1974 Jun 03; 30(22):949-52. PubMed ID: 4601065
    [No Abstract] [Full Text] [Related]

  • 5. [Vitamin K dependent blood clotting proteins (author's transl)].
    Kopeć M.
    Postepy Biochem; 1980 Jun 03; 26(1):3-28. PubMed ID: 6994082
    [No Abstract] [Full Text] [Related]

  • 6. [Studies on plasma hypercoagulability. 1. Heparin resistance in various diseases and its relation to coagulation factors, anticoagulant therapy, platelet and heparin co-factor].
    Satake K.
    Naika Hokan; 1969 Apr 03; 16(4):127-38. PubMed ID: 5816626
    [No Abstract] [Full Text] [Related]

  • 7. Vitamin K--dependent clotting factors.
    Prydz H.
    Semin Thromb Hemost; 1977 Apr 03; 4(1):1-14. PubMed ID: 335512
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Recent advances in the control of anticoagulant therapy.
    Owren PA.
    Geriatrics; 1971 Aug 03; 26(8):74 passim. PubMed ID: 5096463
    [No Abstract] [Full Text] [Related]

  • 11. The relative importance of the factors II, VII, IX and X for the prothrombinase activity in plasma of orally anticoagulated patients.
    Xi M, Béguin S, Hemker HC.
    Thromb Haemost; 1989 Sep 29; 62(2):788-91. PubMed ID: 2814925
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Pharmacology of oral anticoagulants].
    Richter M, Markwardt F.
    Z Gesamte Inn Med; 1979 Jan 01; 34(1):8-17. PubMed ID: 433362
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hemostasis in surgical procedures.
    Quick AJ.
    Surg Gynecol Obstet; 1969 Mar 01; 128(3):523-32. PubMed ID: 4180878
    [No Abstract] [Full Text] [Related]

  • 16. Anticoagulants.
    Forbes CD, Prentice CR.
    Practitioner; 1974 Oct 01; 213(1276 SPEC NO):470-7. PubMed ID: 4617204
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Vitamin K and warfarin. Metabolism, function and interaction.
    Woolf IL, Babior BM.
    Am J Med; 1972 Sep 01; 53(3):261-7. PubMed ID: 5054720
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Action of vitreous body in the blood coagulation].
    Regnault F, Larrieu MJ.
    Pathol Biol (Paris); 1969 Jan 01; 17(1):31-7. PubMed ID: 4895968
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 42.